Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PharmAthene Company Profile (NYSE:PIP)

Consensus Ratings for PharmAthene (NYSE:PIP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $6.00 (265.85% upside)

Analysts' Ratings History for PharmAthene (NYSE:PIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/18/2014Noble FinancialLower Price Target$6.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014AegisBoost Price Target$6.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014HC WainrightInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/2/2013 forward)